Overview

Join this peer-led discussion to dive into the dosing, efficacy, and safety of a once-daily oral treatment option indicated for adult patients with obesity or with overweight in the presence of at least one weight-related comorbidity. Attendees will have the opportunity to ask questions at the conclusion of the program.

Program Objectives
- Summarize the safety and efficacy data for this treatment
- Identify appropriate adult patients
- Provide strategies for initiating and maintaining treatment

This program is sponsored by Lilly USA, LLC.
CMAT-07858 04/2026 © Lilly USA, LLC 2026. All rights reserved.

SPONSORED BY

Eli Lilly & Company